Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000947263-25-000009·Stoke Therapeutics, Inc.
Schedule 13G ownership disclosure
Stoke Therapeutics Inc
Common Stock, $0.0001 par value per share · CUSIP: 86150R107
Event date: 2025-09-30
- Filing-level shares
- 3,173,258
- Percent of class
- 5.8%
- The Toronto-Dominion Bank
Shares: 3,173,258 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947263-25-000009
- Form type
- SCHEDULE 13G
- Filer
- Stoke Therapeutics, Inc.
- CIK
- CIK 1623526
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership